Challenges in Scaling Up Bioprocesses

I’ve been thinking a lot about the common hurdles we face when scaling up bioprocesses. For instance, I’ve often struggled with maintaining product consistency during the transition from lab to pilot plant. I’d love to hear what optimization strategies others have found effective in overcoming these challenges, particularly around bioreactor design and process parameters.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​‍‌⁠‌​‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‍​⁠​‌​⁠‌‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌⁠​⁠‌‍‍‌​⁠‍‌‌‌‌⁠‌⁠‍‌‌​⁠⁠‌⁠​⁠​⁠​‍‌‍‌‍‌​‌‌‌⁠​‌‌​‍‍‌‍⁠​‌⁠‌​‌⁠​‌‌⁠‌‍​‍​‍‌⁠⁠‌​